ES, iPS, MSC, and AFS cells. Stem cells exploitation for Pediatric Surgery: current research and perspective.
Despite the advancements that have been made in treating infants with congenital malformations, these still represent a major cause of disease and death during the first years of life and childhood. Regeneration of natural tissue from living cells to restore damaged tissues and organs is the main purpose of regenerative medicine. This relatively new field has emerged by the combination of tissue engineering and stem cell transplantation as a possible strategy for the replacement of damaged organs or tissues. This review would like to offer an insight on the latest evolution of stem cells with a glance at their possible application for regenerative medicine, particularly in the Paediatric Surgery field.
Pozzobon
Michela
M
Stem Cell Processing Laboratory, Department of Pediatrics, University of Padova, Padova, Italy.
Ghionzoli
Marco
M
De Coppi
Paolo
P
D000653:Amniotic Fluid / Q000166:cytology*; D035843:Biomedical Research / Q000379:methods*; D002648:Child; D000013:Congenital Abnormalities / Q000601:surgery*; D053595:Embryonic Stem Cells / Q000637:transplantation*; D006801:Humans; D057026:Induced Pluripotent Stem Cells / Q000637:transplantation*; D059630:Mesenchymal Stem Cells / Q000166:cytology*; D033581:Stem Cell Transplantation / Q000379:methods*